A new study is set to launch looking at why a few rare cases of people have suffered from severe allergic reactions shortly after receiving mRNA-based COVID-19 vaccine shots.
The U.S. National Institute of Allergy and Infectious Diseases (NIAID) is planning to launch the multi-center study working with the Centers for Disease Control and Prevention (CDC), the U.S. Food and Drug Administration (FDA) and vaccine makers.
The aim of the research is to find out whether people with allergies are at any higher risk of a reaction than those without allergies. Researches also hope to identify the component of the vaccines most likely to be responsible for these potentially life-threatening incidents, known as anaphylaxis.
The study is expected to include several hundred people who have a history of severe allergic reactions to foods, medications or insect stings.
The vaccine will be injected under close medical supervision and set to begin in a matter of weeks.
